Pall Corporation, a global leader in filtration, separation, purification and development and production of therapies and vaccines, plans to establish operations in Duncan, South Carolina. The $ 30.2 million project is expected to create 425 jobs in Spartanburg County.
This new facility, due to be operational in May 2021, will support the rapid development and production of vaccines and therapies, including a COVID-19 vaccine, and will focus primarily on single-use technology, such as the Allegro single-use platform.
“Spartanburg County provides Pall with the diverse workforce we need to manufacture life-saving therapies and vaccines. We hope to build our presence in this county, ”said Pall Life Sciences President Joseph Repp.
The Economic Development Coordinating Council approved job development credits related to the project.
“Pall Corporation’s decision to invest in South Carolina comes at a time when our life sciences industry has evolved into one of our fastest growing industries. The continued development of life sciences will create high-paying jobs that will ensure welfare and prosperity in South Carolina for many years, ”said Governor Henry McMaster.
Pall meets the needs of customers across the broad spectrum of life sciences and industry and works with customers around the world to promote health, safety and environmentally responsible technologies.
“Pall Corporation’s decision to come to Spartanburg is a victory for our county and a victory for our life sciences sector. The variety of investments that reach our county and the diversity of industries that now house Spartanburg are a sign that our future it’s brilliant in the years to come, ”said Spartanburg County Councilor and Chairman of the Economic Development Committee, David Britt.